Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Circulation|May 13, 2021
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial InfarctionKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
European Journal of Heart Failure|March 2, 2026
Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESCKaren Sliwa, Charle Viljoen, Julian Hoevelmann, et al.
European Journal of Heart Failure|August 8, 2024
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of CardiologyKaren Sliwa, Amina Rakisheva, Charle Viljoen, et al.
International Journal of Cardiology|November 18, 2023
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registryKaren Sliwa, Peter van der Meer, Charle Viljoen, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure|June 11, 2021
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM RegistryAlice M Jackson, Mark C Petrie, Alexandra Frogoudaki, et al.
European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.
European Heart Journal|August 26, 2020
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Mark C Petrie, Peter van der Meer, et al.
European Journal of Heart Failure|February 20, 2021
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyKaren Sliwa, Peter van der Meer, Mark C Petrie, et al.
Pageof 3